Natural Alternatives International Inc  (NAII)
Other Ticker:  
Price: $6.6900 $-0.01 -0.149%
Day's High: $6.74 Week Perf: 1.06 %
Day's Low: $ 6.68 30 Day Perf: 14.89 %
Volume (M): 1 52 Wk High: $ 9.44
Volume (M$): $ 8 52 Wk Avg: $6.69
Open: $6.71 52 Wk Low: $5.06

 Market Capitalization (Millions $) 39
 Shares Outstanding (Millions) 6
 Employees 177
 Revenues (TTM) (Millions $) 125
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 4

Natural Alternatives International Inc

Our vision is to enrich the world through the best of nutrition.

We are a leading formulator, manufacturer and marketer of nutritional supplements. Our comprehensive strategic partnerships with our customers offer a wide range of innovative nutritional products and services to our clients including the following: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance.

As our primary business activity, we provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements, as well as other health care products, to consumers both within and outside the U.S. We also own a patent estate related to the ingredient known as beta-alanine, which is primarily commercialized through the direct sale of this raw material under our CarnoSyn® trademark.

Our U.S.-based operations are located in Vista and Carlsbad, California and include manufacturing and distribution, sales and marketing, in-house formulation, laboratory, and other research and development services. Our manufacturing facilities were recertified on December 20, 2012 by the Therapeutic Goods Administration (TGA) of Australia after its audit of our GMP. TGA evaluates new therapeutic products, prepares standards, develops testing methods and conducts testing programs to ensure that products are high in quality, safe and effective. TGA also conducts a range of assessment and monitoring activities including audits of the manufacturing practices of companies who export and sell products to Australia. TGA certification enables us to manufacture products for export into countries that have signed the Pharmaceutical Inspection Convention, which include most European countries as well as several Pacific Rim countries. TGA certifications are generally reviewed every eighteen to thirty six months. During August 2016, TGA completed an inspection of our facility and quality systems for compliance with good manufacturing practices, and a renewed 36 months GMP clearance is expected in the coming months.

Our California facilities also have been awarded GMP registration annually since October 2002 by NSF International (NSF) through the NSF Dietary Supplements Certification Program and received “GMP for Sport” NSF Certified registration on February 16, 2009. GMP requirements are regulatory standards and guidelines establishing necessary processes, procedures and documentation for manufacturers in an effort to assure the products produced by that manufacturer have the identity, strength, composition, quality and purity they are represented to possess. The NSF Certified for Sport program focuses on minimizing the risk that a dietary supplement or sports nutrition product contains banned substances and was developed due to growing demand from athletes and coaches concerned about banned substances in sports supplements. The program focuses primarily on manufacturing and sourcing processes, embedding preventative measures throughout. NAI’s participation in the program allows us to produce products bearing the NSF Sport logo.

Our U.S. operations have also been certified by Health Canada as compliant with GMP requirements as outlined in Part 3 of the Canadian Natural Health Products Regulations. Health Canada is the department of the Canadian government with responsibility for national public health. Health Canada has initiated work to modernize its regulatory system for food and health products. Health Canada plays an active role in ensuring access to safe and effective drugs and health products while giving high priority to public safety and striving to provide information needed to make healthy choices and informed decisions regarding one’s health. NAI was issued its initial certification in December 2011 and received its most recent renewal in November 2015. Not only does this approval demonstrate another level of regulatory compliance for NAI, it may also ease the approval process for our customers who import products into Canada.

During March 2015, our California facilities became certified as Organic Processor and Handler by Natural Food Certifiers (NFC). This certification demonstrates that we meet the USDA National Organic Program standards and allows us to expand our contract manufacturing and packaging services to include Organic labeled products. The certification requires annual renewal and we believe we will obtain renewals annually. We are registered with the State of California, Department of Public Health Food and Drug Branch as an organic processor. Additionally, we are certified by various Rabbinical and Halal authorities to produce Kosher and Halal certified products. These certifications guarantee that the facility, processes, and ingredients of certified products have been reviewed and found to be in compliance with the strict dietary laws of the respective Jewish and Muslim communities

NAIE also operates a manufacturing, warehousing, packaging and distribution facility in Manno, Switzerland. In January 2004, NAIE obtained a pharmaceutical license to process pharmaceuticals for packaging, import, export and sale within Switzerland and other countries from the Swissmedic Authority of Bern, Switzerland.

In addition to our operations in the U.S. and Switzerland, we have had a representative in Japan for many years who provides a range of services to our customers currently present in or seeking to expand into the Japanese market and other markets in the Pacific Rim. These services include regulatory and marketing assistance along with guidance and support in adapting products to these markets.

Our goals are to achieve long-term growth and profitability and to diversify our sales base. To accomplish these goals, we have and intend to continue to seek to do the following:

leverage our state-of-the-art, certified facilities to increase the value of the goods and services we provide to our highly valued private-label contract manufacturing customers and assist in developing relationships with additional quality oriented customers;

expand the commercialization of our beta-alanine patent estate through raw material sales, introduction of new products, new contract manufacturing opportunities, license and sub-license agreements, and protecting our proprietary rights;

provide strategic partnering services to our private-label contract manufacturing customers, as described below under “Products, Principal Markets and Methods of Distribution”; and

improve operational efficiencies and manage costs and business risks to improve profitability.

Overall, we believe there is an opportunity to enhance consumer confidence in the quality of our nutritional supplements and their adherence to label claims through the education provided by direct sales and direct-to-consumer marketing programs. We believe our GMP and TGA certified manufacturing operations, science based product formulations, peer-reviewed clinical studies and regulatory expertise provide us with a sustainable competitive advantage by providing our customers with a high degree of confidence in the products we manufacture.

While today’s consumer may have access to a variety of information, we believe many consumers remain uneducated about nutrition and nutritional supplementation, uncertain about the relevance or reliability of the information available to them, or confused about conflicting claims or information. We believe this state of the market creates a significant opportunity for the direct sales marketing channel. The direct sales marketing channel has proved, and we believe will continue to prove, to be a highly effective method for marketing high-quality nutritional supplements as associates or other individuals educate consumers on the benefits of science based nutritional supplements. Our largest customers operate in the direct sales marketing channel. Thus, the majority of our business has relied primarily on the effectiveness of our customers in this marketing channel.

We also believe there is significant opportunity with the commercialization of our patent estate through the introduction of CarnoSyn® beta-alanine into additional markets and with the introduction of new beta-alanine product offerings. Currently, a majority of our sales of CarnoSyn® are to companies that operate in the sports nutrition channel and are focused on products containing the instant release form of beta-alanine. We believe that there are several other markets and distribution channels that represent growth opportunities for the distribution of CarnoSyn® beta-alanine. We have also recently introduced SR CarnoSyn®, which we believe is a superior form of beta-alanine based on its sustained release profile that allows for increased daily dosing and improved muscle retention of carnosine.

We believe our comprehensive approach to customer service is unique within our industry. We believe this comprehensive approach, together with our commitment to high quality, product development and manufacturing capabilities, will provide the means to implement our strategies and achieve our goals. There can be no assurance, however, that we will successfully implement any of our business strategies or that we will increase or diversify our sales, successfully commercialize our patent estate, or improve our overall financial results.

   Company Address: 1535 Faraday Ave Carlsbad 92008 CA
   Company Phone Number: 736-7700   Stock Exchange / Ticker: NASDAQ NAII

Customers Net Income fell by NAII's Customers Net Profit Margin fell to

-41.06 %

3.07 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
MTEX        7.06% 
GIS   -5.43%    
KHC   -3%    
MDLZ   -1.35%    
PG   -0.46%    
PPC   -0.31%    
• View Complete Report

Natural Alternatives International Inc

Natural Alternatives International Inc. Struggles with Serious Deterioration in Revenue during Second Quarter of 2024 Earnings Season

The financial results of Natural Alternatives International Inc. for the second quarter of 2024 paint a challenging picture for the company. The significant deficit per share, declining revenue, and net loss compared to the previous year all point towards a tough period for the company.
One key highlight from the results is the decline in inventories and the increase in accounts receivable. The decrease in inventories could indicate lower expected demand for the company's products, while the rise in accounts receivable could suggest an increase in sales but delayed payments. These factors can have implications for the company's future performance and growth prospects.

Product Service News

CarnoSyn Brands and Barentz Join Forces to Expand Distribution of CarnoSyn Beta-Alanine in Brazil, Strengthening Brand's Position in the Sports Nutrition Market

Published Thu, Feb 15 2024 4:00 PM UTC

CarnoSyn Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn Beta-AlanineThe sports nutrition industry is witnessing a significant boost in brand expansion and distribution as CarnoSyn Brands, a leading provider of premium sports performance ingredients, announces its partnership with Barentz. This exclusive distribution agreement aims to strengthen...

Natural Alternatives International Inc

Natural Alternatives International Inc faces challenging times during fiscal year 2023 - Financial report reveals struggles and potential setbacks

Natural Alternatives International Inc, a leading player in the supplement industry, recently released its financial results for the fiscal time-frame ending September 30, 2023. The company experienced an increase in losses due to weak demand, resulting in a shortfall per share. However, the legal cannabis sector displayed revenue improvement in the first quarter of 2024, providing a glimmer of hope for Natural Alternatives International Inc. In this article, we will explore how these financial results could impact the company's future operations and prospects.
Declining Revenue and Increased Losses:
In the fiscal time-frame ending September 30, 2023, Natural Alternatives International Inc faced a significant decline in revenue, dropping by -23.164% to $33.14 million compared to $43.13 million in the previous year. This decrease in revenue can be attributed to weak demand in the supplement industry. As a result, the company's losses increased, with a shortfall per share growing from $0.18 to $-0.12 during this time period.

Natural Alternatives International Inc

Natural Alternatives International Inc. Falls Victim to a Startling Revenue Slump in Q4 2023

Natural Alternatives International Inc (NAII) is a company that specializes in providing natural alternatives to conventional products. Their focus is on developing and manufacturing nutritional supplements, including vitamins, minerals, and herbal extracts. They aim to provide high-quality products that promote health and wellness.
However, recent financial reports indicate a decline in performance for the fiscal interval ending June 30, 2023. NAII experienced a loss of $0.50 per share, compared to a profit of $0.52 per share in the previous year. Earnings per share also fell, from $0.41 per share in the preceding reporting period to the current $0.43 per share.

Natural Alternatives International Inc

Despite Net Income Growth, Natural Alternatives International Inc Faces Deteriorating Performance in the Stock Market

When it comes to investing in the stock market, caution is key. The recent performance of Natural Alternatives International Inc (NAII) is a perfect example of why. While their return on equity (ROE) for the third quarter of 2022 was higher than their average, it did diminish compared to the previous quarter despite net income growth. Additionally, while NAII achieved the highest ROE among Legal Cannabis industry peers, their total ranking has deteriorated since the previous quarter.
It's also worth noting that while NAII's earnings per share remained unchanged from the previous year, their revenue stayed flat and their operating earnings fell. All of these factors suggest that NAII's performance may not be as stable or reliable as some investors might like.


Natural Alternatives International Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com